| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.22M | $9.79M | - | |
| CFO | 235.0K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2021 | Leen Ann M.83 | Chief Scientific Officer | Sell | 17,446 | $41.48 | $723,624.58 | -0.1% | |
| Feb 23, 2021 | Vera Juan | Director | Sell | 36,404 | $41.51 | $1,511,309.66 | -0.2% | |
| Feb 23, 2021 | Van Beek Jeroen B85 | Chief Commercial Officer | Sell | 9,083 | $41.46 | $376,620.95 | -0.4% | |
| Feb 22, 2021 | Hagen Brett R84 | Chief Accounting Officer | Sell | 800 | $43.14 | $34,509.04 | -1.2% | |
| Feb 18, 2021 | Van Beek Jeroen B85 | Chief Commercial Officer | Sell | 2,085 | $40.67 | $84,786.79 | -0.1% | |
| Feb 18, 2021 | Leen Ann M.83 | Chief Scientific Officer | Sell | 2,700 | $40.81 | $110,194.24 | - | |
| Feb 18, 2021 | Hagen Brett R84 | Chief Accounting Officer | Sell | 741 | $40.11 | $29,723.67 | -0.6% | |
| Feb 18, 2021 | Brenner Malcolm | Director | Sell | 6,757 | $40.75 | $275,365.77 | -0.2% | |
| Feb 18, 2021 | Vera Juan | Director | Sell | 8,942 | $40.75 | $364,368.36 | -0.1% | |
| Feb 18, 2021 | Bornstein Jeffrey S | Director | Sell | 20,583 | $40.43 | $832,118.83 | -96.2% |